White Paper
Clinical Trial Continuity During COVID-19
COVID-19 is driving change in clinical development, bringing trials closer to patients and expanding regulatory guidance to include virtual trial capabilities – from remote monitoring to telemedicine, direct-to-patient shipment of investigational medicines and the use of home health nurses in clinical research.
Nov 12, 2020
Download

We have entered a new era of clinical development.
In response to COVID-19, the industry brought clinical trials closer to patients – most of whom had to stay at home – at a scale never achieved before. Site access constraints and elevated concerns about patient safety sparked regulatory agencies to expand their guidance to include the use of virtual clinical trial tools.

Many sponsors and clinical research organizations embraced this opportunity to utilize innovative, flexible clinical trials models and approaches to ensure critical drug development continued through the pandemic and beyond.

Related solutions

Contact Us